Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.23Price to Sales
VS
Market
Sector
Industry
History
$ 3.15Close
$ 2.08 - $ 6.95 52-Week Range
Ticker Information
Ticker
VVOSCompany Name
VIVOS THERAPEUTICS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQVIVOS THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VVOS - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 32.05M | 2.23 | $ 14.39M |
| 3/31/2025 | $ 18.02M | 1.23 | $ 14.63M |
| 12/31/2024 | $ 16.79M | 1.12 | $ 15.03M |
| 9/30/2024 | $ 15.09M | 1.03 | $ 14.58M |
| 6/30/2024 | $ 8.06M | 0.57 | $ 14.02M |
| 3/31/2024 | $ 8.04M | 0.6 | $ 13.36M |
| 12/31/2023 | $ 13.19M | 0.96 | $ 13.8M |
| 9/30/2023 | $ 4.47M | 0.31 | $ 14.5M |
| 6/30/2023 | $ 10.27M | 0.66 | $ 15.45M |
| 3/31/2023 | $ 14.07M | 0.87 | $ 16.24M |
Key Performance Insights, Last 5 Years
- VIVOS THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, VIVOS THERAPEUTICS INC's average P/S has been 2.
- The median P/S for VIVOS THERAPEUTICS INC during this period was 1
- VIVOS THERAPEUTICS INC reached its highest P/S over the past 5 years at 9.53.
- The lowest P/S recorded by VIVOS THERAPEUTICS INC in the same timeframe 0.31
VIVOS THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for VIVOS THERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] / Revenues [ $ 11.39M ]
(=) P/S [ 0 ] VVOS - Price to Sales, Last 5 years
0.31
Minimum
Sep 30, 2023
9.53
Maximum
Dec 31, 2020
2
Average
1
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |